Valencia Nutrition Ltd
Incorporated in 2013, Valencia Nutrition Ltd is in the business of developing, manufacturing, sales & distribution of nutraceutical products[1]
- Market Cap ₹ 134 Cr.
- Current Price ₹ 79.1
- High / Low ₹ 97.1 / 35.8
- Stock P/E 45.5
- Book Value ₹ 22.0
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 3.60 times its book value
- Company has high debtors of 279 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Other Beverages
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | TTM | |
|---|---|---|
| 8.47 | 10.62 | |
| 7.70 | 7.67 | |
| Operating Profit | 0.77 | 2.95 |
| OPM % | 9.09% | 27.78% |
| 0.65 | 0.67 | |
| Interest | 0.13 | 0.15 |
| Depreciation | 0.21 | 0.52 |
| Profit before tax | 1.08 | 2.95 |
| Tax % | 0.00% | |
| 1.07 | 2.95 | |
| EPS in Rs | 0.63 | 1.74 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 26% |
| 3 Years: | 86% |
| 1 Year: | 51% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Sep 2025 | |
|---|---|---|
| Equity Capital | 16.98 | 16.98 |
| Reserves | 19.60 | 20.35 |
| 1.49 | 17.79 | |
| 0.35 | 0.80 | |
| Total Liabilities | 38.42 | 55.92 |
| 6.19 | 5.97 | |
| CWIP | 0.00 | 11.85 |
| Investments | 2.93 | 0.92 |
| 29.30 | 37.18 | |
| Total Assets | 38.42 | 55.92 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | 279.24 |
| Inventory Days | 216.24 |
| Days Payable | 10.57 |
| Cash Conversion Cycle | 484.91 |
| Working Capital Days | 734.31 |
| ROCE % |
Documents
Announcements
-
Intimation Regarding Applicability Of Disclosure Of Related Party Transactions Pursuant To SEBI Circular Dated November 11, 2024
1d - Valencia to submit half-yearly related party transactions disclosure for period ended 30 Sep 2025.
-
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended September, 2025.
1d - No deviation; Rights Rs21.78Cr, Preferential/Warrants Rs32.07Cr fully utilised for H1 Sep 30, 2025.
-
Outcome Of Board Meeting Held On November 13, 2025 For The Approval Of Unaudited Financial Results For The Half-Year Ended September 2025
1d - Approved H1 FY2026 results: revenue Rs361.65L, profit Rs59.30L; unmodified limited review.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, November 13, 2025 For The Approval Of Unaudited Financial Results For The Half-Yearl Ended September 30, 2025
1d - Board approved H1 results to Sept 30, 2025: revenue Rs361.65 lakh, profit Rs59.30 lakh; auditors' unmodified review.
-
Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Financial Results For The Half Year Ended September 30, 2025
5 Nov - Board meeting Nov 13, 2025 to approve unaudited H1 standalone and consolidated results; trading window closed.
Business Overview:[1][2]
VNL is a BSE Start Up Listed Corporate Company since January 2020. It is an applied biotechnology company focused on research, developing & marketing Ready to Drink nutraceuticals, Ready-to-Mix nutraceuticals (Ease Out Sachets) viz. AL Cans, Sachets, PET bottles, PET Cans, Tetra Pack, and Refreshment Mints etc. to prevent or manage lifestyle related diseases